7 results on '"SEVİNİR, BETÜL BERRİN"'
Search Results
2. Evaluation of the Lag Time Between Onset of Symptoms and Diagnosis in Childhood Cancers.
- Author
-
Kalay, Gülşah, Sevinir, Betül Berrin, Demirkaya, Metin, Aygüneş, Utku, and Ertekin, Mehtap
- Subjects
- *
DELAYED diagnosis , *GERMINOMA , *NEUROBLASTOMA , *LIVER tumors , *TIME , *RETROSPECTIVE studies , *ACQUISITION of data , *TUMORS in children , *MEDICAL records , *KIDNEY tumors , *EARLY diagnosis , *SYMPTOMS ,DIAGNOSIS of tumors in children - Abstract
Introduction: Our aim was to evaluate the lag time between the first onset of symptoms and the final diag-nosis in children with lymphoma and solid tumors. Materials and Methods: This study was carried out by retrospectively scanning the records of 759 patients admitted to the Pediatric Oncology Department of Uludağ University between January 2005 and December 2014. Demographic data of the patients, first complaints, the time to apply to a physician after the first complaint, the first application center were determined, lag time to the center that established the oncologic diagnosis, the final diagnosis, time to diagnosis at the last center, total time elapsed from the first onset of complaints to the establishment of diagnosis and the last health state of the patient were obtained from the hospital records. Results: The patients diagnosed with cancer firstly applied to a physician median 15 days. The physicianwho saw the patient for the first time referred to him/her to the center that established the final diagnosis after a median of 8 days. The median time to final diagnosis was 10 days minimum 1 days and totaly 55 days at the last center. In patients whose first symptom is fever, abdominal pain and seizures and In patients with a definitive diagnosis of germ cell tumor, neuroblastoma, kidney tumor and liver tumor, the time to the first admission was shorter than 15 days. In patients whose first symptom was a headache, and abdominal mass; in patients and central nervous system (CNS), and eyes, and in patients with the final diagnosis of CNS tumor germ cell tumor and retinoblastoma, the lag times for referrals were significantly shorter than 8 days. In patients whose first symptom was headache, nausea and vomiting, fatigue-weight loss, and visual disturbances and in patients with the final diagnosis of CNS tumors and neuroendocrine tumors, the time to diagnosis was significantly shorter than 10 days. Conclusion: Delays in diagnosis are common in children with cancer. A sustained effort should be made to raise the level of awareness of childhood cancer among parents and to sensitize all physicians, especially those who treat pediatric patients infrequently, about the warning signs of the disease. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. T‐cell/histiocyte‐rich large B‐cell lymphoma in a patient with a novel frameshift MSH6 mutation.
- Author
-
Cekic, Sukru, Aydin, Firdevs, Karali, Yasin, Sevinir, Betül Berrin, Canoz, Ozlem, Boztug, Kaan, Unal, Ekrem, and Kilic, Sara Sebnem
- Published
- 2023
- Full Text
- View/download PDF
4. A prospective follow-up of quality of life, depression, and anxiety in children with lymphoma and solid tumors.
- Author
-
SARGIN YILDIRIM, Nihal, DEMİRKAYA, Metin, SEVİNİR, Betül Berrin, GÜLER, Salih, VURAL, Ayşe Pınar, DEMİRÖZ, Candan, and ÇIRPAN KANTARCIOĞLU, Arzu
- Subjects
QUALITY of life ,MENTAL depression ,ANXIETY ,LYMPHOMAS in children ,TUMORS - Abstract
Background/aim: The aim of this study was the determination and prospective follow-up of quality of life, depression, and anxiety in pediatric patients with cancer under chemotherapy, as well as the evaluation of related factors. Materials and methods: Fifty newly diagnosed pediatric cancer patients and their parents were prospectively monitored before, during, and after therapy, and tests were used. Results: Significantly lower quality of life scores were recorded during treatment, in the group with CNS tumors, in the group receiving chemotherapy plus radiotherapy plus surgery, in the inpatient-only treatment group, in the group receiving treatment for longer than 6 months, and in the group of patients whose diagnosis was delayed for more than 3 months. Total quality of life scores for children and their parents were 82.95 ± 14.59 vs. 83.61 ± 14.60 before, 54.69 ± 16.51 vs. 55.78 ± 16.05 during, and 83.88 ± 12.44 vs. 84.19 ± 13.22 at the end of treatment (P < 0.05). Anxiety and depression scores were significantly higher during treatment, in patients whose diagnoses were delayed for more than 3 months, and among inpatients. Conclusion: The quality of life of a majority of our patients was severely affected, and depression and anxiety were more frequently seen especially during treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
5. Epstein-Barr Virus Enfeksiyonlarının Tanısında PCR Sonuçlarının Değerlendirilmesi.
- Author
-
KARADAĞ GEÇGEL, Sanem, ERSOY, Alparslan, SEVİNİR, Betül Berrin, SINIRTAŞ, Melda, and GÖRAL, Güher
- Published
- 2012
6. Catheter-associated Bloodstream Infections in Pediatric Hematology-Oncology Patients
- Author
-
Adalet Meral Güneş, Solmaz Celebi, Mustafa Hacimustafaoglu, Deniz Çakır, Metin Demirkaya, Sefika Elmas Bozdemir, Melike Evim Sezgin, Birol Baytan, Betül Sevinir, Uludağ Üniversitesi/Tıp Fakültesi/Pediatri Anabilim Dalı., Çelebi, Solmaz, Sezgin, Melike Evim, Çakır, Deniz, Baytan, Birol, Demirkaya, Metin, Sevinir, Betül Berrin, Bozdemir, Şefika Elmas, Güneş, Adalet Meral, Hacımustafaoğlu, Mustafa Kemal, and AAH-1570-2021
- Subjects
Male ,Complications ,medicine.medical_treatment ,Bacteremia ,Acute lymphoblastic leukemia ,Pediatrics ,Neuroblastoma ,Catheters, Indwelling ,Recurrence ,Risk Factors ,Neoplasms ,Catheter-associated bloodstream infection ,Enterococcus faecalis ,Prospective Studies ,Child ,Children ,Cancer ,Pediatric ,Fungus ,Solid tumor ,Mortality rate ,Candidiasis ,Hematology ,Childhood mortality ,Recurrent infection ,Prognosis ,Death ,Survival Rate ,Retrospective study ,Catheter ,Oncology ,Child, Preschool ,Lines ,Female ,Hypotension ,Childhood cancer ,Central venous catheter ,Gram positive cocci ,Human ,Catheterization, Central Venous ,medicine.medical_specialty ,Neutropenia ,Adolescent ,Catheter infection ,Clinical article ,Pediatric Hematology/Oncology ,Gram negative bacterium ,Cancer mortality ,Article ,Internal medicine ,medicine ,Device ,Humans ,Catheter removal ,Vascular Access Devices ,Central Venous Catheters ,Implant ,Coagulase negative Staphylococcus ,Bacteria ,business.industry ,Prevention ,Infant ,Acute lymphoblastic-leukemia ,medicine.disease ,Child care ,Surgery ,Outcome assessment ,Preschool child ,Reinfection ,Catheter-Related Infections ,Pediatrics, Perinatology and Child Health ,Cancer patient ,School child ,Risk factor ,Human medicine ,business ,Removal ,Hospitalized child ,Follow-Up Studies - Abstract
Catheter-associated bloodstream infections (CABSIs) are common complications encountered with cancer treatment. The aims of this study were to analyze the factors associated with recurrent infection and catheter removal in pediatric hematology-oncology patients. All cases of CABSIs in patients attending the Department of Pediatric Hematology-Oncology between January 2008 and December 2010 were reviewed. A total of 44 episodes of CABSIs, including multiple episodes involving the same catheter, were identified in 31 children with cancer. The overall CABSIs rate was 7.4 infections per 1000 central venous catheter (CVC) days. The most frequent organism isolated was coagulase-negative Staphylococcus (CONS). The CVC was removed in nine (20.4%) episodes. We found that hypotension, persistent bacteremia, Candida infection, exit-side infection, neutropenia, and prolonged duration of neutropenia were the factors for catheter removal. There were 23 (52.2%) episodes of recurrence or reinfection. Mortality rate was found to be 9.6% in children with CABSIs. In this study, we found that CABSIs rate was 7.4 infections per 1000 catheter-days. CABSIs rates in our hematology-oncology patients are comparable to prior reports. Because CONS is the most common isolated microorganism in CABSIs, vancomycin can be considered part of the initial empirical regimen.
- Published
- 2013
- Full Text
- View/download PDF
7. Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin’s lymphoma and acute lymphoblastic leukemia
- Author
-
Metin Demirkaya, Betül Sevinir, Birol Baytan, Adalet Meral Güneş, Uludağ Üniversitesi/Tıp Fakültesi/Pediatrik Hematoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Pediatrik Onkoloji Anabilim Dalı., Sevinir, Betül Berrin, Demirkaya, Metin, Baytan, Birol, Güneş, Adalet Meral, and AAH-1570-2021
- Subjects
Male ,Urate oxidase rasburicase ,medicine.medical_treatment ,Hydration ,Acute lymphoblastic leukemia ,Gastroenterology ,chemistry.chemical_compound ,hemic and lymphatic diseases ,Hyperuricemia ,Child ,Children ,Cancer ,Leukemia ,Incidence ,Incidence (epidemiology) ,Lactate dehydrogenase ,Non-Hodgkin's lymphoma ,lcsh:Diseases of the blood and blood-forming organs ,Hematology ,Kidney disease ,Management ,Tumor lysis syndrome ,Retrospective study ,Hemodialysis ,Nonhodgkin lymphoma ,Female ,Human ,medicine.drug ,lcsh:Internal medicine ,medicine.medical_specialty ,Adolescent ,Allopurinol ,Major clinical study ,Article ,Internal medicine ,medicine ,lcsh:RC31-1245 ,Disease severity ,Tumor Lysis Syndrome ,Rasburicase ,Hyperphosphatemia ,Clinical characteristics ,lcsh:RC633-647.5 ,Urate oxidase ,business.industry ,Prevention ,Infant ,medicine.disease ,Childhood ,Lymphoma ,Outcome assessment ,Leukocyte count ,Clinical feature ,Lactate dehydrogenase blood level ,Preschool child ,chemistry ,Non-Hodgkin’s lymphoma ,Laboratory diagnosis ,Uric acid ,School child ,business - Abstract
This study aimed to examine the incidence, clinical characteristics, and outcome of hyperuricemia and tumor lysis syndrome (TLS) in children with non-Hodgkin's lymphoma (NHL) and acute lymphoblastic leukemia (ALL).This retrospective study included data from 327 patients (113 NHL and 214 ALL).Hyperuricemia occurred in 26.5% and 12.6% of the patients with NHL and ALL, respectively. The corresponding figures for TLS were 15.9% and 0.47% (p=0.001). All hyperuricemic NHL patients had advanced disease and renal involvement was present in 53%. All hyperuricemic ALL patients had a leukocyte count50,000 mm3 at the time of diagnosis. Among the hyperuricemic NHL and ALL patients, 96.6% and 66.6% had LDH ≥500 UI/L, respectively. Treatment consisted of hydration and allopurinol; none of the patients received urate oxidase. Among the patients that developed TLS, 26.3% had laboratory TLS, 42.1% had grade I or II TLS, and 31.6% had grade III or IV TLS. Uric acid levels returned to normal after a mean period of 3.5±2.5 and 3.05±0.8 d in NHL and ALL groups, respectively. In all, 7% of the patients with hyperuricemia required hemodialysis. None of the patients died.In this series the factors associated with a high-risk for TLS were renal involvement in NHL and high leucocyte count in ALL. Management with allopurinol and hydration was effective in this group of patients with high tumor burden.AMAÇ: Çalışmanın amacı NHL ve ALL’li çocuklarda hiperürisemi ve TLS sıklığını, klinik özellikleri ve sonuçlarını tanımlamaktır. YÖNTEMLER: Bu retrospektif çalışmada 113 NHL ve 214 ALL’li toplam 327 hastanın verileri değerlendirildi.NHL olgularının %26.5’inde, ALL olgularının %12.6’sında hiperürisemi görüldü. TLS insidansı NHL ve ALL gruplarında %15.9 ve %0.47 bulundu (p=0.001). Hiperürisemi görülen NHL olgularının tümü ileri evrede olup, %53’ünde renal tutulum vardı. Tüm hiperürisemili ALL olgularında tanıda lökosit sayımı 50.000/mm3’den yüksekti. Hiperürisemik NHL grubunun %96.6’sında, ALL grubunun %66.6’sında LDH ≥500 UI/L idi. Tedavide hidrasyon ve allopürinol uygulandı, ürat oksidaz verilen hasta olmadı. TLS gelişen olguların %26.3’ünde laboratuvar TLS, %42,1’inde grade I ve grade II TLS, %31.6’sında grade III ve IV TLS saptandı. Ürik asit düzeyleri NHL ve ALL hastalarında ortalama 3.5±2.5 ve 3.05±0.8 günde normale döndü. Hiperürisemili hastaların %7’sinde hemodiyaliz gerekti. Mortalite olmadı. SONUÇ: Bu seride en yüksek TLS riski renal tutulumu olan NHL olgularında saptandı. Allopürinol ve hidrasyonun tümör yükü yüksek olan bu grupta etkili olduğu gözlendi.
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.